1. Endosialin defines human stem Leydig cells with regenerative potential
   Kai Xia et al, 2020, Human Reproduction CrossRef
2. Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
   Daniel J. O’Shannessy et al, 2016, Sarcoma CrossRef
3. Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
   Emily Capone et al, 2017, Oncotarget CrossRef
4. New molecular insights into osteosarcoma targeted therapy
   Jilong Yang et al, 2013, Current Opinion in Oncology CrossRef
5. Endosialin-expressing bone sarcoma stem-like cells are highly tumor-initiating and invasive
   DONG-XIU SUN et al, 2015, Molecular Medicine Reports CrossRef
6. Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer
   Chunsheng Li et al, 2014, Oncotarget CrossRef
7. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
   Khin Thway et al, 2016, British Journal of Cancer CrossRef
8. Role of C-Type Lectins in the Tumor Microenvironment
   Kasturi Ganguly et al, 2023, Handbook of Cancer and Immunology CrossRef
9. C‐type lectin domain group 14 proteins in vascular biology, cancer and inflammation
   Kabir A. Khan et al, 2019, The FEBS Journal CrossRef
10. TEM1 expression in cancer‐associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer
    Satoshi Fujii et al, 2015, Cancer Medicine CrossRef
11. Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications
    Sara E.S. Lange et al, 2016, Oncotarget CrossRef
12. Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
    Sara R. Martins-Neves et al, 2022, International Journal of Molecular Sciences CrossRef